GEVORKYAN as
PSE:GEV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GEVORKYAN as
PSE:GEV
|
SK |
|
Binect AG
XETRA:MA10
|
DE |
|
Mold-Tek Technologies Ltd
NSE:MOLDTECH
|
IN |
|
N
|
Novo Nordisk A/S
XBER:NOVA
|
DK |
|
C
|
Cronos Group Inc
NASDAQ:CRON
|
CA |
|
H
|
Hunan Gold Corp Ltd
SZSE:002155
|
CN |
|
Smaregi Inc
TSE:4431
|
JP |
|
NBT Bancorp Inc
NASDAQ:NBTB
|
US |
|
A
|
Aallon Group Oyj
OMXH:AALLON
|
FI |
Income Statement
Earnings Waterfall
GEVORKYAN as
Income Statement
GEVORKYAN as
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
48
N/A
|
42
-12%
|
59
+39%
|
|
| Gross Profit | ||||
| Cost of Revenue |
(33)
|
(27)
|
(36)
|
|
| Gross Profit |
16
N/A
|
15
-4%
|
23
+51%
|
|
| Operating Income | ||||
| Operating Expenses |
(9)
|
(8)
|
(14)
|
|
| Selling, General & Administrative |
(3)
|
(4)
|
(5)
|
|
| Depreciation & Amortization |
(6)
|
(4)
|
(9)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
|
| Operating Income |
7
N/A
|
7
0%
|
9
+30%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
(2)
|
(2)
|
(3)
|
|
| Non-Reccuring Items |
0
|
(0)
|
0
|
|
| Total Other Income |
0
|
(1)
|
(1)
|
|
| Pre-Tax Income |
5
N/A
|
4
-27%
|
5
+31%
|
|
| Net Income | ||||
| Tax Provision |
(1)
|
(1)
|
(1)
|
|
| Income from Continuing Operations |
4
|
3
|
4
|
|
| Net Income (Common) |
4
N/A
|
3
-29%
|
4
+32%
|
|
| EPS (Diluted) |
0.27
N/A
|
0.19
-30%
|
0.21
+11%
|
|